Next Article in Journal / Special Issue
Exome Sequencing in Fetuses with Structural Malformations
Previous Article in Journal
Hepatic Atypical Protein Kinase C: An Inherited Survival-Longevity Gene that Now Fuels Insulin-Resistant Syndromes of Obesity, the Metabolic Syndrome and Type 2 Diabetes Mellitus
Previous Article in Special Issue
The Psychological Challenges of Replacing Conventional Karyotyping with Genomic SNP Array Analysis in Prenatal Testing
J. Clin. Med. 2014, 3(3), 741-746; doi:10.3390/jcm3030741
Communication

Pregnancy Loss Following Amniocentesis or CVS Sampling—Time for a Reassessment of Risk

1,*  and 2,3
Received: 31 March 2014; in revised form: 24 May 2014 / Accepted: 29 May 2014 / Published: 8 July 2014
(This article belongs to the Special Issue Prenatal Genetic Screening and Diagnosis-Part 2)
View Full-Text   |   Download PDF [165 KB, uploaded 8 July 2014]
Abstract: Risk of procedure-related pregnancy loss is currently widely quoted in the UK as 1% for amniocentesis and 1.5% for chorionic villus sampling. Published data suggest that these risk figures are out of date and inaccurate, and that new guidelines are required for pre-test counseling. It is our opinion that accurate and evidence-based information concerning miscarriage risk is vital when counseling women, as exaggeration of this risk may deter women from testing, or cause unjustified remorse if a miscarriage ensues. It is also essential that health-care economists are aware of the up-to-date evidence on “procedure-related risk” when applying risk-benefit analysis to assess new technology for non-invasive screening.
Keywords: miscarriage; procedure-related pregnancy loss; amniocentesis; chorionic villus sampling (CVS); non-invasive prenatal testing; cell free fetal DNA miscarriage; procedure-related pregnancy loss; amniocentesis; chorionic villus sampling (CVS); non-invasive prenatal testing; cell free fetal DNA
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ogilvie, C.; Akolekar, R. Pregnancy Loss Following Amniocentesis or CVS Sampling—Time for a Reassessment of Risk. J. Clin. Med. 2014, 3, 741-746.

AMA Style

Ogilvie C, Akolekar R. Pregnancy Loss Following Amniocentesis or CVS Sampling—Time for a Reassessment of Risk. Journal of Clinical Medicine. 2014; 3(3):741-746.

Chicago/Turabian Style

Ogilvie, Caroline; Akolekar, Ranjit. 2014. "Pregnancy Loss Following Amniocentesis or CVS Sampling—Time for a Reassessment of Risk." J. Clin. Med. 3, no. 3: 741-746.


J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert